These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8265870)

  • 1. Initial empiric therapy for fever in neutropenia.
    Bustamante CI
    Recent Results Cancer Res; 1993; 132():45-56. PubMed ID: 8265870
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of empiric vancomycin therapy in children with fever and neutropenia.
    Adcock KG; Akins RL; Farrington EA
    Pharmacotherapy; 1999 Nov; 19(11):1315-20. PubMed ID: 10555937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fever in patients with cancer].
    Watanabe K
    Rinsho Byori; 2009 May; Suppl 143():112-5. PubMed ID: 20845880
    [No Abstract]   [Full Text] [Related]  

  • 4. The child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategies.
    Pizzo PA; Rubin M; Freifeld A; Walsh TJ
    J Pediatr; 1991 Nov; 119(5):679-94. PubMed ID: 1941374
    [No Abstract]   [Full Text] [Related]  

  • 5. Fever, neutropenia, and the second law of thermodynamics.
    Baden LR; Rubin RH
    Ann Intern Med; 2002 Jul; 137(2):123-4. PubMed ID: 12118968
    [No Abstract]   [Full Text] [Related]  

  • 6. Current considerations in the management of fever and neutropenia.
    Alexander SW; Pizzo PA
    Curr Clin Top Infect Dis; 1999; 19():160-80. PubMed ID: 10472485
    [No Abstract]   [Full Text] [Related]  

  • 7. Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient.
    Granowetter L; Wells H; Lange BJ
    Pediatr Infect Dis J; 1988 Mar; 7(3):165-70. PubMed ID: 3282214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fever and neutropenia during intensive chemotherapy.
    Klastersky J
    Ann Oncol; 1993 Aug; 4(7):603-6. PubMed ID: 8363991
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients.
    Raad II; Whimbey EE; Rolston KV; Abi-Said D; Hachem RY; Pandya RG; Ghaddar HM; Karl CL; Bodey GP
    Cancer; 1996 Apr; 77(7):1386-94. PubMed ID: 8608520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fever and neutropenia in children with cancer: diagnostic parameters at presentation.
    Riikonen P; Jalanko H; Hovi L; Saarinen UM
    Acta Paediatr; 1993 Mar; 82(3):271-5. PubMed ID: 8495083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient.
    Ramphal R; Gucalp R; Rotstein C; Cimino M; Oblon D
    Am J Med; 1996 Jun; 100(6A):83S-89S. PubMed ID: 8678102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefepime vs. Meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours.
    Kutluk T; Kurne O; Akyüz C; Ceyhan M; Kanra G; Büyükpamukçu M; Seçmeer G
    Pediatr Blood Cancer; 2004 Mar; 42(3):284-6. PubMed ID: 14752869
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cefepime as an empiric treatment of febrile neutropenia in patients after high dose therapy and autologous stem cell transplantation].
    Zikesoá E; Hnátková M; Vacková B; Jedlicková A; Klener P; Trnený M
    Cas Lek Cesk; 2006; 145(5):383-6, 388-9. PubMed ID: 16755776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empiric antimicrobial therapy in the community hospital setting for the cancer patient with fever and neutropenia: the need for vigilance and attention to detail.
    Gallagher JG
    Recent Results Cancer Res; 1993; 132():89-96. PubMed ID: 8265874
    [No Abstract]   [Full Text] [Related]  

  • 15. Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia.
    Montalar J; Segura A; Bosch C; Galan A; Juan O; Molins C; Giner V; Aparicio J
    Med Oncol; 2002; 19(3):161-6. PubMed ID: 12482126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fever and neutropenia: changing patterns of medical practice.
    Arceci RJ
    J Pediatr Hematol Oncol; 2000; 22(5):397. PubMed ID: 11037846
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibiotic management of febrile neutropenia: current developments and future directions.
    Mebis J; Goossens H; Berneman ZN
    J Chemother; 2010 Feb; 22(1):5-12. PubMed ID: 20227985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fever and granulocytopenia: a viewpoint from an academic setting.
    Vogelzang NJ; Flaherty JP
    Recent Results Cancer Res; 1993; 132():79-88. PubMed ID: 8265873
    [No Abstract]   [Full Text] [Related]  

  • 19. 2nd International Symposium on Febrile Neutropenia, Brussels, 14-16 December 1995.
    Hess U
    Support Care Cancer; 1996 Jul; 4(4):320-1. PubMed ID: 8829314
    [No Abstract]   [Full Text] [Related]  

  • 20. Low risk episodes of fever and neutropenia in pediatric oncology: Is outpatient oral antibiotic therapy the new gold standard of care?
    Ammann RA; Simon A; de Bont ES
    Pediatr Blood Cancer; 2005 Sep; 45(3):244-7. PubMed ID: 15747334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.